Do viruses play a role in Alzheimer’s disease?
New research by NIH-funded scientists has revealed evidence that viral species, particularly herpesviruses, could contribute toward the complex biology underlying Alzheimer’s disease.
Browsing: Alzheimer’s disease
Alzheimer’s disease: The Longest Day – a note from the Editor
To mark The Longest Day campaign by the Alzheimer’s Association, we’ve brought together all our Alzheimer’s disease content for you to browse.
Alzheimer’s disease: Phase III clinical trials of lanabecestat to discontinue
An independent data monitoring committee has advised that lanabecestat is unlikely to meet primary endpoints, leading to the decision to discontinue trials.
While we wait for effective treatments, what else can research deliver for people with dementia?
Alzheimer’s Society has worked with an expert taskforce to develop goals and detailed recommendations for research into dementia prevention, diagnosis, intervention and care by 2025.
UK Biobank: new genetic risk factors for Alzheimer’s disease identified
Researchers have uncovered three new genes that are linked to the possibility of developing Alzheimer’s disease; potentially unlocking new treatment possibilities for patients.
Dementia exercise programs may not slow cognitive decline, study indicates
A recent trial has determined that moderate-to-high intensity exercise does not slow cognitive decline in individuals with dementia.
New study suggests the need for early detection of Alzheimer’s disease pathology
Researchers have suggested that anti-amyloid therapies would be most effective before individuals reach the threshold for preclinical Alzheimer’s disease.
Azeliragon fails Phase III trial for Alzheimer’s disease: industry news round-up
In this week’s industry news round-up we set the focus on Alzheimer’s disease (AD), with another clinical trial termination announced and a new framework for defining AD.
Do HIV-associated neurological disorders have shared mechanisms with Alzheimer’s disease?
New research has suggested that a protein involved in Alzheimer’s disease may also be implicated in HIV-associated neurological disorders, suggesting Alzheimer’s therapies may benefit a subset of HIV patients.
NCTalks with Tara Spires-Jones: ApoE4, synapse degeneration and Alzheimer’s
Prof Spires-Jones chats to Lauren Pulling about synapse degeneration in Alzheimer’s, as well as the importance of mentoring in science.
